Cassia tora (Leguminosae) seed extract alleviates high-fat diet-induced nonalcoholic fatty liver

Food and Chemical Toxicology

Volumn 51, Issue 1, 2013, Pages 194-201

  Tzeng, Thing Fong ^a   Lu, Hung Jen ^b   Liou, Shorong Shii ^c   Chang, Chia Ju ^d   Liu, I Min ^c  

^a Pao Chien Hospital   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAJEN UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

AMP activated protein kinase; Cassia tora seeds; Fatty liver; High fat diet

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPID; PLANT EXTRACT; SENNA TORA EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PLANT SEED; RAT; SENNA TORA; SIGNAL TRANSDUCTION; UPREGULATION;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BODY WEIGHT; CASSIA; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FATTY LIVER; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIPIDS; MALE; OBESITY; PHOSPHORYLATION; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS; TRIGLYCERIDES;

FABACEAE; RATTUS;

EID: 84867768492     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.09.024     Document Type: Article

References (32)

1. Abbott R.D., Wilson P.W., Kannel W.B., Castelli W.P. High density lipoprotein-cholesterol, total cholesterol screening and myocardial infarction. The Framingham Study. Arterosclerosis 1988, 8:207-211.
2. Ahmed M.H., Byrne C.D. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discovery Today 2007, 12:740-747.
3. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999, 94:2467-2474.
4. Choi J.S., Lee H.J., Park K.Y., Ha O.J., Kang S.S. In vitro antimutagenic effects of anthraquinone aglycones and naphthopyrone glycosides from Cassia tora. Planta Med. 1997, 63:11-14.
5. Choudhary M., Gulia Y., Nitesh Cassia tora: its chemistry, medical uses and pharmacology. Pharmacologyonline 2011, 3:78-96.
6. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-506.
7. Friedewald W.T., Levy R., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
8. Guan Y., Zhao S. Yishou jiangzhi (de-blood-lipid) tablets in the treatment of hyperlipidemia. J. Tradit. Chin. Med. 1995, 15:178-179.
9. Hagen R.M., Rodriguez-Cuenca S., Vidal-Puig A. An allostatic control of membrane lipid composition by SREBP1. FEBS Lett. 2010, 584:2689-2698.
10. Han C., Wang J., Li L., Zhang Z., Wang L., Pan Z. The role of insulin and glucose in goose primary hepatocyte triglyceride accumulation. J. Exp. Biol. 2009, 212:1553-1558.
11. Jang D.S., Lee G.Y., Kim Y.S., Lee Y.M., Kim C.S., Yoo J.L., Kim J.S. Anthraquinones from the seeds of Cassia tora with inhibitory activity on protein glycation and aldose reductase. Biol. Pharm. Bull. 2007, 30:2207-2210.
12. Kim Y.M., Lee C.H., Kim H.G., Lee H.S. Anthraquinones isolated from Cassia tora (Leguminosae) seed show an antifungal property against phytopathogenic fungi. J. Agric. Food Chem. 2004, 52:6096-6100.
13. Kohjima M., Higuchi N., Kato M., Kotoh K., Yoshimoto T., Fujino T., Yada M., Yada R., Harada N., Enjoji M., Takayanagi R., Nakamuta M. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int. J. Mol. Med. 2008, 21:507-511.
14. Lee G.Y., Jang D.S., Lee Y.M., Kim J.M., Kim J.S. Naphthopyrone glucosides from the seeds of Cassia tora with inhibitory activity on advanced glycation end products (AGEs) formation. Arch. Pharmacal Res. 2006, 29:587-590.
15. Li Y., Xu S., Mihaylova M.M., Zheng B., Hou X., Jiang B., Park O., Luo Z., Lefai E., Shyy J.Y., Gao B., Wierzbicki M., Verbeuren T.J., Shaw R.J., Cohen R.A., Zang M. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011, 13:376-388.
16. Liu J.F., Ma Y., Wang Y., Du Z.Y., Shen J.K., Peng H.L. Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress. Phytother. Res. 2011, 25:588-596.
17. Longo N., di San Amat., Filippo C., Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am. J. Med. Genet. C. Semin. Med. Genet. 2006, 142C:77-85.
18. Malterud K.E., Farbrot T.L., Huse A.E., Sund R.B. Antioxidant and radical scavenging effects of anthraquinones and anthrones. Pharmacology 1993, 47:77-85.
19. Mensink R.P., Plat J., Schrauwen P. Diet and nonalcoholic fatty liver disease. Curr. Opin. Lipidol. 2008, 19:25-29.
20. Moore J.B. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc. Nutr. Soc. 2010, 69:211-220.
21. Musso G., Gambino R., Cassader M. Emerging molecular targets for the treatment of nonalcoholic fatty liver disease. Annu. Rev. Med. 2010, 61:375-392.
22. Neuschwander-Tetri B.A., Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003, 37:1202-1219.
23. Patil U.K., Saraf S., Dixit V.K. Hypolipidemic activity of seeds of Cassia tora Linn. J. Ethnopharmacol. 2004, 90:249-252.
24. Ramirez-Zacarias J.L., Castro-Munozledo F., Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil Red O. Histochemistry 1992, 97:493-497.
25. Shanmugasundaram K.R., Visvanathan A., Dhandapani K., Srinivasan N., Rasappan P., Gilbert R., Alladi S., Kancharla S., Vasanthi N. Effect of high-fat diet on cholesterol distribution in plasma lipoproteins, cholesterol esterifying activity in leucocytes, and erythrocyte membrane components studied: importance of body weight. Am. J. Clin. Nutr. 1986, 44:805-815.
26. Smith B.W., Adams L.A. Non-alcoholic fatty liver disease. Crit. Rev. Clin. Lab. Sci. 2011, 48:97-113.
27. Tessari P., Coracina A., Cosma A., Tiengo A. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 2009, 19:291-302.
28. Van Heek M., Compton D.S., France C.F., Tedesco R.P., Fawzi B., Graziano M.P., Sybertz E.J., Strader C.D., Davis H.R. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J. Clin. Invest. 1997, 99:385-390.
29. Viollet B., Guigas B., Leclerc J., Hébrard S., Lantier L., Mounier R., Andreelli F., Foretz M. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol. (Oxf) 2009, 196:81-98.
30. Wong S.M., Wong M.M., Seligmann O., Wagner H. New antihepatotoxic naphtho-pyrone glycosides from the seeds of Cassia tora. Planta Med. 1989, 55:276-280.
31. Wu C.H., Yen G.C. Antigenotoxic properties of Cassia tea (Cassia tora L.): mechanism of action and the influence of roasting process. Life Sci. 2004, 76:85-101.
32. Xu Z.J., Fan J.G., Ding X.D., Qiao L., Wang G.L. Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Dig. Dis. Sci. 2010, 55:931-940.